FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 126 filers reported holding FATE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,536,000 | +41.8% | 144,340 | +3.5% | 0.00% | 0.0% |
| Q4 2018 | $1,788,000 | -40.6% | 139,394 | -24.5% | 0.00% | +50.0% |
| Q3 2018 | $3,010,000 | +191.4% | 184,722 | +102.8% | 0.00% | +100.0% |
| Q2 2018 | $1,033,000 | +24.2% | 91,078 | +6.9% | 0.00% | 0.0% |
| Q1 2018 | $832,000 | +91.7% | 85,232 | +20.1% | 0.00% | 0.0% |
| Q4 2017 | $434,000 | +54.4% | 70,992 | 0.0% | 0.00% | – |
| Q3 2017 | $281,000 | +20.6% | 70,992 | -1.4% | 0.00% | – |
| Q2 2017 | $233,000 | – | 71,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |